Loading...
Clearside Biomedical, Inc.
CLSD•NASDAQ
Healthcare
Biotechnology
$0.50
$-0.04(-7.72%)
Clearside Biomedical, Inc. (CLSD) Financial Performance & Income Statement Overview
Review Clearside Biomedical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-79.77%
↓ 79.77%
Operating Income Growth
-16.25%
↓ 16.25%
Net Income Growth
-5.75%
↓ 5.75%
Operating Cash Flow Growth
-36.19%
↓ 36.19%
Operating Margin
-1804.60%
↓ 1804.60%
Gross Margin
89.61%
↑ 89.61%
Net Profit Margin
-2148.61%
↓ 2148.61%
ROE
83.36%
↑ 83.36%
ROIC
-176.57%
↓ 176.57%
Clearside Biomedical, Inc. (CLSD) Income Statement & Financial Overview
Review Clearside Biomedical, Inc.'s (CLSD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $306000.00 | $1.04M | $90000.00 | $230000.00 |
| Cost of Revenue | $149000.00 | $0.00 | $0.00 | $28000.00 |
| Gross Profit | $157000.00 | $1.04M | $90000.00 | $202000.00 |
| Gross Profit Ratio | $0.51 | $1.00 | $1.00 | $0.88 |
| R&D Expenses | $4.24M | $4.13M | $4.60M | $5.59M |
| SG&A Expenses | $3.06M | $2.84M | $3.08M | $2.82M |
| Operating Expenses | $7.31M | $6.97M | $7.68M | $8.41M |
| Total Costs & Expenses | $7.46M | $6.97M | $7.68M | $8.44M |
| Interest Income | $358000.00 | $338000.00 | $419000.00 | $348000.00 |
| Interest Expense | $2.58M | $2.46M | $2.34M | $2.40M |
| Depreciation & Amortization | $79000.00 | $75000.00 | $44000.00 | $28000.00 |
| EBITDA | -$4.65M | -$5.16M | -$5.21M | -$9.33M |
| EBITDA Ratio | -$15.19 | -$4.97 | -$57.89 | -$40.57 |
| Operating Income | -$7.15M | -$5.93M | -$7.59M | -$8.21M |
| Operating Income Ratio | -$23.36 | -$5.72 | -$84.33 | -$35.69 |
| Other Income/Expenses (Net) | -$157000.00 | -$1.75M | -$4000.00 | -$3.55M |
| Income Before Tax | -$7.31M | -$7.69M | -$7.59M | -$11.76M |
| Income Before Tax Ratio | -$23.88 | -$7.41 | -$84.38 | -$51.14 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.31M | -$7.69M | -$7.59M | -$11.76M |
| Net Income Ratio | -$23.88 | -$7.41 | -$84.38 | -$51.14 |
| EPS | -$0.10 | -$0.10 | -$0.10 | -$0.17 |
| Diluted EPS | -$0.10 | -$0.10 | -$0.10 | -$0.17 |
| Weighted Avg Shares Outstanding | $75.85M | $74.75M | $74.73M | $69.85M |
| Weighted Avg Shares Outstanding (Diluted) | $75.85M | $74.75M | $74.73M | $69.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan